Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Austin Baraki

Obesity Medicine · Vineyard Health

View

Dr. Priya Jaisinghani

Obesity Medicine · NYU Langone

View

Dr. Jodi Nagelberg

Obesity Medicine · UCSD

View

Dr. Maria Fleseriu

Neuroendocrinology · OHSU Hospital

View

Dr. John Stafford

General Endocrinology · OSUMC

View

Dr. David Cohen

Thyroid · RU

View

Dr. Susan Spratt

Diabetes · Duke

View

Dr. James Findling

Adrenal Diseases · Froedtert

View

Dr. Anupam Kotwal

Thyroid · UNMC

View

Dr. William Young

Adrenal Diseases · Mayo Clinic College of Medicine

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    EBDr. Eliot Brinton

    Dr. Eliot Brinton

    Endocrinology · Obesity Medicine & Nutrition
    University of Utah
    eliot

    Research

    Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study

    2026

    Via Menopause

    Research

    Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial

    2026

    Via Alzheimer's & Dementia

    Research

    Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT

    2026

    Via European Journal of Preventive Cardiology

    Research

    Evinacumab in patients aged 5-17 years with homozygous familial hypercholesterolemia

    2025

    Via Atherosclerosis

    Feb 19, 2025Journal Article

    Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.

    ​
    ​

    Written by 2 Roon authors & 11 others

    Via The American Heart Association Journals

    Research

    Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA

    2025

    Via Atherosclerosis

    Research

    Long-term effects of 4 years of menopausal hormone therapy on white matter integrity

    2025

    Via Menopause

    Research

    Impact of Batoclimab Treatment on LDL-C with and Without Coadministration of Atorvastatin: Results from a Phase I Randomized Study in Healthy Participants

    2025

    Via Drug Safety

    Research

    Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT

    2025

    Via European Journal of Preventive Cardiology

    Research

    Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged <5 Years With Homozygous Familial Hypercholesterolemia

    2025

    Via CPT: Pharmacometrics & Systems Pharmacology

    Research

    Evinacumab in patients aged 5–17 years with homozygous familial hypercholesterolemia

    2025

    Via Atherosclerosis

    Research

    Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM

    2025

    Via American Journal of Preventive Cardiology

    Research

    Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

    2024

    Via European Heart Journal

    Research

    Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl

    2024

    Via Journal of the American College of Cardiology

    Research

    Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention

    2024

    Via Journal of Clinical Lipidology